Filter announcements
Loading...
Kopran Ltd. is an integrated Pharmaceutical Company, committed to manufacture and supply International Quality Formulations and Active Pharmaceutical Ingredients worldwide.
Kopran experienced a cybersecurity incident involving unauthorized access to its server data. The company has secured systems and is working with experts to assess the potential impact on operations.
GST authorities are conducting a search at Kopran's office and facilities. The company is cooperating, and officials have not shared details of any alleged violations. Operations remain normal with no financial impact reported.
Kopran Research Laboratories Limited, a wholly owned subsidiary of Kopran Ltd., has successfully concluded a recent USFDA surveillance inspection at its API unit in Mahad, Maharashtra. The inspection, conducted from April 21 to April 25, 2025, concluded without any observations, suggesting a clean report, which typically reflects positively on the...
The Board has approved the merger of Kopran Laboratories Limited with Kopran Limited, pending necessary approvals from the Stock Exchange, SEBI, and shareholders. The merger is structured as a share exchange ratio, where 100 equity shares of Kopran Limited will be allocated for every 45 shares of Kopran Laboratories. Kopran...